Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis.
| Publication Type | Letter |
| Authors | Krueger J, Murrell D, Garcet S, Navrazhina K, Lee P, Muscianisi E, Blauvelt A |
| Journal | J Allergy Clin Immunol |
| Volume | 147 |
| Issue | 3 |
| Pagination | 1107-1109.e2 |
| Date Published | 09/28/2020 |
| ISSN | 1097-6825 |
| Keywords | Angiotensin-Converting Enzyme 2, Anti-Inflammatory Agents, Antibodies, Monoclonal, Humanized, Psoriasis, Skin |
| DOI | 10.1016/j.jaci.2020.09.021 |
| PubMed ID | 33002515 |
| PubMed Central ID | PMC7834246 |
